How To Track Brain Health (Before It Slips)
How do you track brain health before symptoms appear? Proactive brain health tracking involves measuring three distinct domains: Risk (vascular and metabolic drivers), Performance (cognitive baselines in memory and processing speed), and Structure (advanced imaging like MRI). Rather than waiting for memory lapses, cognitive baselines established early allow for longitudinal tracking to detect subtle shifts decades before a potential dementia diagnosis.
What’s in this post?
The Problem with Waiting: Why standard screenings often miss early decline.
The Three Domains: Risk, Performance, and Structure.
The Silent Drivers: Identifying the variables we revisit.
Cognitive Baselines: Why your "normal" might actually be a decline.
Advanced Diagnostics: The role of MRI and blood-based biomarkers.
The Longitudinal System: How Ikigai stays ahead of brain aging.
Why is waiting for memory symptoms a mistake?
Most people think about brain health the wrong way. They wait. They wait for memory lapses. For word-finding difficulty. For a moment that feels just a little off—and then they wonder if it means something more.
But by the time symptoms show up, the underlying biology has often been developing for years—sometimes decades. In many neurodegenerative conditions, measurable changes can begin 10–20 years before anything feels wrong.
That’s the central problem with waiting. We approach the brain the same way we approach preventive cardiology, metabolic health, and cancer risk: we don’t wait for symptoms. We measure brain health early, track over time, and intervene when there’s still an opportunity to change trajectory.
This is the foundation of our Brain Health Program—and it starts with understanding what we’re actually trying to measure.
What are the three domains of brain health?
The goal isn’t just “memory.” In the last article, we walked through the major drivers of dementia risk—including the broader framework described by the Lancet Commission, which outlines multiple modifiable factors that shape brain health over time.
Your brain health is shaped by three broad domains:
Risk – the factors that increase the likelihood of future decline
Performance – how your brain is functioning today
Structure – what the brain physically looks like beneath the surface
If you only measure one of these, you miss the full picture. Most traditional care focuses on performance—and usually only after symptoms appear. We take a more comprehensive approach.
Which "silent drivers" increase dementia risk?
Long before cognition changes, risk accumulates. High blood pressure. Poor sleep. Insulin resistance. Hearing loss. Chronic stress. Physical inactivity. Social isolation.
None of these feel like “brain issues” in the moment. But over time, they quietly shape the environment your brain lives in. We don’t treat these as a checklist. We treat them as variables that need to be tracked and revisited.
These are not measured once and forgotten. We track them as part of a system we follow—revisiting them over time to detect change early and adjust accordingly. Vascular health influences blood flow and oxygen delivery. Metabolic health affects how the brain uses energy. Sleep plays a critical role in clearing metabolic waste and maintaining neural function.
Why is a cognitive baseline essential for performance?
The second layer is understanding how your brain is functioning today—not compared to a population average, but compared to you, over time. We use structured cognitive testing to establish a baseline across key domains:
Memory
Attention
Processing speed
Executive function
This isn’t about labeling someone as “normal” or “abnormal.” It’s about creating a reference point. Without a baseline, you’re guessing. With a baseline, you can track change—subtle shifts that would otherwise go unnoticed. Importantly, brief screening tools often miss early change. A person can score “normal” and still be declining relative to their own baseline. That’s why longitudinal tracking—not a single test—is what matters most.
When should you use MRI or biomarkers for brain health?
In select cases, we go one step further—looking at the brain itself. Advanced imaging, most commonly MRI, can provide insight into brain volume, regional changes involved in memory, and vascular contributions to brain health.
Where biomarkers and genetics fit: Blood-based biomarkers for neurodegenerative disease are improving rapidly. Today, we use them selectively in patients with higher risk. We also assess genetics, including the APOE gene. Importantly, genetics influence probability—they do not determine destiny. These tools add context but do not replace the need for longitudinal clinical judgment.
How does Ikigai build a longitudinal system for brain longevity?
The biggest misconception in brain health is that decline is sudden. It’s not. It’s gradual. And because it’s gradual, it’s easy to miss—until it isn’t.
This is the framework every patient at Ikigai moves through. It’s not a one-time evaluation. It’s a longitudinal system built around:
Tracking factors that influence your brain over time.
Establishing and repeating cognitive baselines to detect subtle change.
Integrating tools like imaging, biomarkers, and genetics when appropriate.
Because the brain doesn’t exist in isolation, our interventions are integrated with your cardiovascular and metabolic care. This is how we stay ahead of brain aging—not by waiting or guessing, but by measuring early, thoughtfully, and consistently over time.
